Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 13, 2021 (5 years ago)

Mit/B12 25/50/50mg/Ml 1mg/Ml Mdv

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

MIT/B12 25/50/50MG/ML 1MG/ML MDV, Rx only, Red Mountain Compounding Rx

Recalling firm
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
Origin
AZ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0065-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

All 2021 recalls

Other sterility / contamination recalls from 2021

All sterility / contamination recalls